Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive Malignant Neoplasm of Breast

Explore clinical trials studying Hormone Receptor Positive Malignant Neoplasm of Breast. Study availability and eligibility vary by location and protocol.

15 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Hormone Receptor Positive Malignant Neoplasm of Breast trial results

Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Conditions
Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +20 more
Locations
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 63 locations
View Trial Details
Recruiting

A Study of Revaree Plus in People With Breast Cancer

NCT07042581

Conditions
Breast Cancer, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk-Commack (Consent Only) Commack, New York, United States
View Trial Details
Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Completed

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT06253195

Conditions
Advanced Solid Tumor, Breast Cancer, Breast Diseases, +14 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South) Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
View Trial Details
Completed

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

NCT02668666

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +8 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Michigan State University Lansing, Michigan, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

NCT04483505

Conditions
Breast Cancer Metastatic, Hormone Receptor Positive Malignant Neoplasm of Breast
Locations
  • Institut Català d'oncologia - Hospital Duran I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain
  • Hospital Quirónsalud Madrid Pozuelo de Alarcón, Madrid, Spain
  • Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain
View Trial Details
Completed

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

NCT03969121

Conditions
Breast Cancer Female, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Monash Health Clayton, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • UNIMED Medical Institute Hong Kong
  • Amagasaki General Medical Center Amagasaki, Hyōgo, Japan
View all 25 locations
View Trial Details
Completed

Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer

NCT03088527

Conditions
Hormone Receptor Positive Malignant Neoplasm of Breast
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Cancer Center Protocol Office Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Center Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions